Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraglandular Salivary Corticosteroid Injections to Prevent Radiation-Induced Xerostomia
NCT07802977Phase 1Completed
- Sponsor
- University of California, Davis
- Start
- Jul 2020
- Primary completion
- Jul 2022
- Countries
- 1
01
Overview
Phase 1, open-label trial of dexamethasone in xerostomia (2 arms), sponsored by University of California, Davis. Primary endpoint: Number of Missed or Delayed Days of Radiation Therapy Due to Steroid Injection up to 6 weeks. Started Jul 2020; status: completed.
02
Drugs
dexamethasone
03
Conditions
xerostomia
Beyond the preview
Go deeper on NCT07802977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07802977.